About Aizon
Aizon is a company based in San Francisco (United States) founded in 2014 by Pere Merino, Toni Manzano, and Pep Gubau. Aizon has raised $44.65 million across 5 funding rounds from investors including Honeywell, KROHNE and NewVale Capital. Aizon offers products and services including Aizon Execute, Aizon Unify, Aizon Predict, and Aizon Consulting. Aizon operates in a competitive market with competitors including Apprentice, PLAIO, Enzyme Technology, Seal and LunarTree, among others.
- Headquarter San Francisco, United States
- Founders Pere Merino, Toni Manzano, Pep Gubau
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bigfinite Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$44.65 M (USD)
in 5 rounds
-
Latest Funding Round
$20 M (USD), Series C
Feb 07, 2024
-
Investors
Honeywell
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aizon
Aizon offers a comprehensive portfolio of products and services, including Aizon Execute, Aizon Unify, Aizon Predict, and Aizon Consulting.
Handles AI-driven manufacturing batch processing and recipe execution.
Offers intelligent lakehouse for batch review and real-time monitoring.
Optimizes yield and reduces deviations using AI predictions.
Adapts AI solutions to specific pharma needs for quick results.
People of Aizon
Unlock access to complete
Unlock access to complete
Funding Insights of Aizon
Aizon has successfully raised a total of $44.65M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $20 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Aizon
Aizon has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Honeywell, KROHNE and NewVale Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
NewVale Capital is focused on life sciences investment.
|
Locked | Locked | Locked | |
|
Atlantic Bridge is focused on growth equity investments in technology.
|
Locked | Locked | Locked | |
|
Venture capital is invested in various sectors by Crosslink Capital.
|
Locked | Locked | Locked |
Investor details for Aizon
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aizon
Investment portfolio details for Aizon
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aizon
Detailed financials for Aizon
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aizon Comparisons
Peer comparison for Aizon
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aizon
Aizon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Apprentice, PLAIO, Enzyme Technology, Seal and LunarTree, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based tools for pharmaceutical manufacturing management are offered.
|
|
| Locked | Locked | Locked |
AI-based planning solutions are provided for pharmaceutical industries.
|
|
| Locked | Locked | Locked |
AI-based enzymatic DNA synthesis technology is provided for researchers.
|
|
| Locked | Locked | Locked |
Seal is recognized as an AI-native GxP execution platform.
|
|
| Locked | Locked | Locked |
AI platform aggregates biopharma data for accelerated life sciences decisions.
|
Detailed competitors of Aizon
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aizon
Complete news archive for Aizon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aizon
Aizon was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Aizon is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
John Vitalie is the current CEO of Aizon.
Aizon is a funded company, having raised a total of $44.65M across 5 funding rounds to date.
Aizon was founded in 2014 and is based in San Francisco, United States. SAAS solutions powered by AI are offered for manufacturing operations, with a focus on big data analytics and predictive insights. Industries served include biotech and pharma, cosmetics, medical devices, chemicals, nutraceuticals, and food and beverage. Solutions encompass performance management, anomaly detection, batch process optimization, and related areas.
Aizon's top competitors include Apprentice, PLAIO and Seal.
Aizon offers Aizon Execute, Aizon Unify, Aizon Predict, and Aizon Consulting.
Aizon has 10 investors. Key investors include Honeywell, KROHNE, NewVale Capital, Atlantic Bridge, and Crosslink Capital.